TESARO, Inc. Gives Notice of Anticipated Make-Whole Adjustment Event to Holders of Its Convertible Senior Notes Dec 4, 2018 04:15PM
TESARO, Inc. Gives Notice of Anticipated Make-Whole Adjustment Event to Holders of Its Convertible Senior Notes Dec 4, 2018 04:15PM
GlaxoSmithKline (GSK) to Acquire TESARO (TSRO) for $5.1B Dec 3, 2018 07:05AM
GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company Dec 3, 2018 07:04AM
GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company Dec 3, 2018 07:04AM
View Older Stories

Nov 9, 2018 03:43PM TESARO (TSRO) Announces Immuno-Oncology Data Presentations at SITC
Nov 9, 2018 03:41PM TESARO Announces Immuno-Oncology Data Presentations at SITC 2018 Annual Meeting
Nov 9, 2018 03:41PM TESARO Announces Immuno-Oncology Data Presentations at SITC 2018 Annual Meeting
Nov 1, 2018 04:05PM TESARO Announces Third-Quarter 2018 Operating Results
Nov 1, 2018 04:05PM TESARO Announces Third-Quarter 2018 Operating Results
Oct 30, 2018 08:05AM The Foundation for Women’s Cancer and TESARO Partner on the Race to End Women’s Cancer for 3rd Year
Oct 30, 2018 08:05AM The Foundation for Women’s Cancer and TESARO Partner on the Race to End Women’s Cancer for 3rd Year
Oct 24, 2018 08:00AM TESARO and Actress Cobie Smulders Launch Not on My Watch, a National Movement to Empower the Ovarian Cancer Community
Oct 24, 2018 08:00AM TESARO and Actress Cobie Smulders Launch Not on My Watch, a National Movement to Empower the Ovarian Cancer Community
Oct 22, 2018 06:13AM TESARO (TSRO) Reports Updated Phase 1 GARNET Data of TSR-042 (anti-PD-1 antibody) in Patients with Recurrent or Advanced MSI-H
Oct 20, 2018 01:30AM TESARO Announces Data Presentations at ESMO 2018 Congress
Oct 20, 2018 01:30AM TESARO Announces Data Presentations at ESMO 2018 Congress
Oct 18, 2018 04:15PM TESARO to Announce Third-Quarter 2018 Financial Results on November 1, 2018
Oct 18, 2018 04:15PM TESARO to Announce Third-Quarter 2018 Financial Results on November 1, 2018
Oct 9, 2018 08:16AM TESARO (TSRO) Announces Data Presentations at ESMO
Oct 9, 2018 08:15AM TESARO Announces Data Presentations at the ESMO 2018 Congress
Oct 9, 2018 08:15AM TESARO Announces Data Presentations at the ESMO 2018 Congress
Oct 1, 2018 06:15PM TESARO Announces Data Presentations at the SITC 2018 Annual Meeting
Oct 1, 2018 06:15PM TESARO Announces Data Presentations at the SITC 2018 Annual Meeting
Sep 19, 2018 04:15PM TESARO Announces Participation at Two Investor Conferences
Sep 19, 2018 04:15PM TESARO Announces Participation at Two Investor Conferences
Aug 27, 2018 08:00AM TESARO Announces Participation at Three Investor Conferences
Aug 27, 2018 08:00AM TESARO Announces Participation at Three Investor Conferences
Aug 2, 2018 04:05PM TESARO Announces Second-Quarter 2018 Operating Results
Aug 2, 2018 04:05PM TESARO Announces Second-Quarter 2018 Operating Results
Jul 20, 2018 04:15PM TESARO to Announce Second-Quarter 2018 Financial Results on August 2, 2018
Jul 20, 2018 04:15PM TESARO to Announce Second-Quarter 2018 Financial Results on August 2, 2018
Jul 2, 2018 09:00AM TESARO Partners With the Pan-Mass Challenge for 2018 Ride Benefiting Dana-Farber Cancer Institute
Jul 2, 2018 09:00AM TESARO Partners With the Pan-Mass Challenge for 2018 Ride Benefiting Dana-Farber Cancer Institute
Jun 29, 2018 04:21PM TESARO (TSRO) Draws $200 Million From Second Tranche of Non-Dilutive Term Loan Financing
Jun 29, 2018 04:05PM TESARO Draws $200 Million From Second Tranche of Non-Dilutive Term Loan Financing
Jun 29, 2018 04:05PM TESARO Draws $200 Million From Second Tranche of Non-Dilutive Term Loan Financing
Jun 28, 2018 04:06PM TESARO (TSRO) Enters Asset Purchase Agreement with TerSera Therapeutics LLC for VARUBI in U.S. and Canada
Jun 28, 2018 04:05PM TESARO Enters Asset Purchase Agreement with TerSera® Therapeutics LLC for VARUBI® in the U.S. and Canada
Jun 28, 2018 04:05PM TESARO Enters Asset Purchase Agreement with TerSera® Therapeutics LLC for VARUBI® in the U.S. and Canada
Jun 5, 2018 08:31AM TESARO (TSRO) Announces Collaboration to Evaluate ZEJULA in Combination With Anti-PD-L1 Cancer Immunotherapy and MEK Inhibitor in Platinum-Sensitive Ovarian Cancer
Jun 5, 2018 08:30AM TESARO Announces Collaboration to Evaluate ZEJULA® in Combination With Anti-PD-L1 Cancer Immunotherapy and MEK Inhibitor in Platinum-Sensitive Ovarian Cancer
Jun 5, 2018 08:30AM TESARO Announces Collaboration to Evaluate ZEJULA® in Combination With Anti-PD-L1 Cancer Immunotherapy and MEK Inhibitor in Platinum-Sensitive Ovarian Cancer
Jun 5, 2018 05:53AM TESARO (TSRO) Highlights TOPACIO and QUADRA Trial Results Presented at 2018 ASCO Annual Meeting
Jun 4, 2018 06:00PM TESARO Summarizes TOPACIO and QUADRA Trial Results Presented at 2018 ASCO Annual Meeting
Jun 4, 2018 06:00PM TESARO Summarizes TOPACIO and QUADRA Trial Results Presented at 2018 ASCO Annual Meeting
Jun 1, 2018 06:18AM TESARO (TSRO) Reports Addition of ZEJULA to Cancer Drugs Fund in UK
Jun 1, 2018 03:00AM TESARO Announces Addition of ZEJULA to Cancer Drugs Fund in UK
Jun 1, 2018 03:00AM TESARO Announces Addition of ZEJULA to Cancer Drugs Fund in UK
Jun 1, 2018 03:00AM TESARO Announces Addition of ZEJULA to Cancer Drugs Fund in UK
May 16, 2018 05:16PM TESARO (TSRO) Announces Presentations of Abstracts at ASCO
May 16, 2018 05:15PM TESARO Announces Presentations of Abstracts at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
May 16, 2018 05:15PM TESARO Announces Presentations of Abstracts at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
May 3, 2018 04:05PM TESARO Announces First-Quarter 2018 Operating Results
May 3, 2018 04:05PM TESARO Announces First-Quarter 2018 Operating Results
View Older Stories